Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (17)

2021

  1. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

2018

  1. Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia

    Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1213.e1-1213.e4

2017

  1. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  2. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2014

  1. Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal

    Medicine (United States), Vol. 93, Núm. 5, pp. 202-210

2012

  1. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1

  2. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Farmacia Hospitalaria, Vol. 36, Núm. 1

2011

  1. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  2. Health-care-associated bloodstream infections at admission to the ICU

    Chest, Vol. 139, Núm. 4, pp. 810-815

  3. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  4. Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document

    Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39

  5. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85

  6. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

    Intensive Care Medicine, Vol. 37, Núm. 2, pp. 272-283

2010

  1. Política de antibióticos en pacientes críticos

    Medicina Intensiva, Vol. 34, Núm. 9, pp. 600-608

2006

  1. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study

    Critical Care, Vol. 10, Núm. 3